Novo Nordisk A/S (NYSE:NVO) is included among the 10 Best Affordable Blue Chip Stocks to Buy Now. Novo Nordisk A/S (NYSE:NVO) ...

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

As artificial intelligence continues to rewrite the rules in countless industries, pharma companies are increasingly getting ...

This deal comes as the total value of AI partnerships takes a 120% uptick year-on-year between 2024 and 2025, as per ...

Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology ...

By Maggie Fick LONDON, April 14 (Reuters) - Danish drugmaker Novo Nordisk, which has fallen behind Eli Lilly in the immensely ...

Novo Nordisk announced a strategic partnership with OpenAI on April 14. Here is what the deal covers and what it means for ...

Novo Nordisk has become the latest big pharma group to forge an alliance with AI giant OpenAI, seeking to turbocharge its ...

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to ...

Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a ...

Novo Nordisk partners with OpenAI to accelerate drug discovery using AI across research manufacturing and operations globally ...

The pharma giant will deploy OpenAI’s most advanced capabilities across its global operations, from drug discovery to ...